share_log

ImmunoPrecise Antibodies | SC 13D: Statement of acquisition of beneficial ownership by individuals-Ingalls & Snyder, LLC(4.22%)

ImmunoPrecise Antibodies | SC 13D:超過5%持股股東披露文件-Ingalls & Snyder, LLC(4.22%)

SEC announcement ·  2023/07/07 15:22
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息